Back to Search
DONALD DURDEN, MD, PHD
MD, PHD
Pediatric Hematology & Oncology Physician
NPI: 1841340395Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
G75994(CA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
G75994(CA)
Research & Publications (20)
Positive and negative electrospray LC-MS-MS methods for quantitation of the antiparasitic endectocide drugs, abamectin, doramectin, emamectin, eprinomectin, ivermectin, moxidectin and selamectin in milk.
PMID 17129769·J Chromatogr B Analyt Technol Biomed Life Sci·2007
7-preclinical
Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent.
PMID 10640511·Drug Metab Dispos·2000
7-preclinical
In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells.
PMID 19636556·Cancer Chemother Pharmacol·2010
8-other
Regulation of XIAP translation and induction by MDM2 following irradiation.
PMID 19411066·Cancer Cell·2009
8-other
Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
PMID 19276385·Cancer Res·2009
8-other
PI-3 kinase-PTEN signaling node: an intercept point for the control of angiogenesis.
PMID 19199965·Curr Pharm Des·2009
6-review
Expression of RAC2 in endothelial cells is required for the postnatal neovascular response.
PMID 19123268·Exp Cell Res·2009
7-preclinical
The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
PMID 18339867·Cancer Res·2008
7-preclinical
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.
PMID 18172313·Cancer Res·2008
7-preclinical
Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins.
PMID 18056377·J Immunol·2007
7-preclinical
Mechanisms of disease: the PI3K-Akt-PTEN signaling node--an intercept point for the control of angiogenesis in brain tumors.
PMID 18046441·Nat Clin Pract Neurol·2007
6-review
Ivermectin use and resulting milk residues on 4 Canadian dairy herds.
PMID 17824327·Can Vet J·2007
7-preclinical
CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation.
PMID 17325034·Mol Cell Biol·2007
7-preclinical
A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
PMID 17213812·Oncogene·2007
8-other
Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase.
PMID 16931516·J Biol Chem·2006
7-preclinical
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms.
PMID 16849552·Cancer Res·2006
8-other
'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.
PMID 16783163·J Neuropathol Exp Neurol·2006
6-review
A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging.
PMID 15957510·Mult Scler·2005
3-trial
CSK negatively regulates nerve growth factor induced neural differentiation and augments AKT kinase activity.
PMID 15890337·Exp Cell Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3010 CHILDRENS WAY
SAN DIEGO, CA 92123 - Phone
- (858) 966-5811
Quick Facts
- NPI
- 1841340395
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile